Evidence map›Paper›PMID 29669924›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2018

SAMHD1 enhances immunoglobulin hypermutation by promoting transversion mutation.

Eddy Sanchai Thientosapol, Daniel Bosnjak, Timothy Durack, Igor Stevanovski, Michelle van Geldermalsen, Jeff Holst, Zeenat Jahan, Caitlin Shepard, Wolfgang Weninger, Baek Kim and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. SAMHD1 in cancer: curse or cure?Journal of molecular medicine (Berlin, Germany) · 2022
    Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 3 countries.

Eddy Sanchai ThientosapolCentenary Institute, Camperdown NSW 2050, Australia.
Daniel BosnjakCentenary Institute, Camperdown NSW 2050, Australia.
Timothy DurackCentenary Institute, Camperdown NSW 2050, Australia.
Igor StevanovskiCentenary Institute, Camperdown NSW 2050, Australia.
Michelle van GeldermalsenCentenary Institute, Camperdown NSW 2050, Australia.
Jeff HolstCentenary Institute, Camperdown NSW 2050, Australia.
Zeenat JahanCentenary Institute, Camperdown NSW 2050, Australia.
Caitlin ShepardEmory School of Medicine, Emory University, Atlanta, GA 30322.
Wolfgang WeningerCentenary Institute, Camperdown NSW 2050, Australia.
Baek KimEmory School of Medicine, Emory University, Atlanta, GA 30322.
Robert BrinkGarvan Institute of Medical Research, Darlinghurst, Sydney, NSW 2010, Australia.
Christopher J JollyCentenary Institute, Camperdown NSW 2050, Australia; c.jolly@centenary.org.au.ORCID 0000-0002-9307-1056
The University of Sydney · AUEmory University · USGarvan Institute of Medical Research · AU

Funding

Replication fidelity and lentiviral pathogenesisR01AI049781 · NIAID · UNIVERSITY OF ROCHESTER · PI KIM, BAEK · 2002 to 2016
$4.9M
SAMHD1 controls dNTP pool and HIV sensitivity to NRTIsR01GM104198 · NIGMS · UNIVERSITY OF ROCHESTER · PI KIM, BAEK · 2012 to 2018
$2.3M
Replicational Fidelity and Lentivial PathogenesisR56AI049781 · NIAID · EMORY UNIVERSITY · PI KIM, BAEK · 2017 to 2017
$390k
NIAID NIH HHS R01 AI049781NIAID NIH HHS R56 AI049781NIGMS NIH HHS R01 GM104198
6 · The paper itself

Abstract

Activation-induced deaminase (AID) initiates hypermutation of

Indexed as

Lymphocyte ActivationMutationSAM Domain and HD Domain-Containing Protein 1AICDA (Activation-Induced Cytidine Deaminase)AnimalsB-LymphocytesCytidine DeaminaseDNA-Directed DNA PolymeraseG1 PhaseMaleMiceMice, TransgenicNucleotidyltransferasesSomatic Hypermutation, ImmunoglobulinY-Family DNA PolymerasesAICDA (Activation-Induced Cytidine Deaminase)Cytidine DeaminaseDNA-Directed DNA PolymeraseNucleotidyltransferasesRev1 protein, mouseSAM Domain and HD Domain-Containing Protein 1Samhd1 protein, mouseY-Family DNA PolymerasesB cellsdeaminationDNA repairdNTPsmutation

Identifiers

PMID29669924
PMCPMC5948975
OpenAlexW2802876043

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.